Cargando…

Correction: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy

Detalles Bibliográficos
Autores principales: Jugniot, Natacha, Dahl, Jeremy J., Paulmurugan, Ramasamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789608/
https://www.ncbi.nlm.nih.gov/pubmed/36564801
http://dx.doi.org/10.1186/s13046-022-02577-x
_version_ 1784858992040738816
author Jugniot, Natacha
Dahl, Jeremy J.
Paulmurugan, Ramasamy
author_facet Jugniot, Natacha
Dahl, Jeremy J.
Paulmurugan, Ramasamy
author_sort Jugniot, Natacha
collection PubMed
description
format Online
Article
Text
id pubmed-9789608
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97896082022-12-25 Correction: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy Jugniot, Natacha Dahl, Jeremy J. Paulmurugan, Ramasamy J Exp Clin Cancer Res Correction BioMed Central 2022-12-24 /pmc/articles/PMC9789608/ /pubmed/36564801 http://dx.doi.org/10.1186/s13046-022-02577-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Jugniot, Natacha
Dahl, Jeremy J.
Paulmurugan, Ramasamy
Correction: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
title Correction: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
title_full Correction: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
title_fullStr Correction: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
title_full_unstemmed Correction: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
title_short Correction: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
title_sort correction: immunotheranostic microbubbles (imbs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789608/
https://www.ncbi.nlm.nih.gov/pubmed/36564801
http://dx.doi.org/10.1186/s13046-022-02577-x
work_keys_str_mv AT jugniotnatacha correctionimmunotheranosticmicrobubblesimbsamodularplatformfordendriticcellvaccinedeliveryappliedtobreastcancerimmunotherapy
AT dahljeremyj correctionimmunotheranosticmicrobubblesimbsamodularplatformfordendriticcellvaccinedeliveryappliedtobreastcancerimmunotherapy
AT paulmuruganramasamy correctionimmunotheranosticmicrobubblesimbsamodularplatformfordendriticcellvaccinedeliveryappliedtobreastcancerimmunotherapy